Lobbying Filing Details

Total Spending

$50,000

Activities

2

Lobbyists

6

Gov't Entities

4

Filing Information

Filing UUID:: b21517bf-701e-4f23-90f0-08198bcc9549
Type:: Q1 - 1st Quarter - Report
Period:: 2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:: April 20, 2026 at 8:03 PM
Income:: $50,000
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: James "J.D." Derderian

Registrant

STANTON PARK GROUP

government affairs

Annapolis, Maryland

Client

BRAEBURN PHARMACEUTICALS, INC.

pharmaceutical company

New Jersey, United States of America

Lobbying Activities (2)

Activity 1

Health Issues

Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; Patient access to practitioner-administered therapies

Lobbyists (6)

VALERIE HENRY
JAMES DERDERIAN
JOSEPH RACHINSKY JR
MR. BRYAN WILLIAM WELLS
AISLING MCDONOUGH
KEVIN DAWSON

Government Entities (2)

SENATE
HOUSE OF REPRESENTATIVES

Activity 2

Medicare/Medicaid

Pilot programs related to Medicaid pricing

Lobbyists (6)

VALERIE HENRY
JAMES DERDERIAN
JOSEPH RACHINSKY JR
MR. BRYAN WILLIAM WELLS
AISLING MCDONOUGH
KEVIN DAWSON

Government Entities (2)

SENATE
HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.